coadministered cagrilintide and semaglutide in adults with overweight or obesity the REDEFINE 2 phase 3a trial involving diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide–semaglutide (CagriSema) versus semaglutide or
Description
Its having a moment, with claims that it boosts hair, nails, skin and joint health
00125-7/asset/25d10da2-038c-4d13-b485-c9856810af68/main.assets/gr3_lrg.jpg)
Revealing the complexity of meniscus microvasculature through 3D visualization and analysis
Lalinde-Acevedo PC, Mayorga-Torres BJM, Agarwal A, et al
00402-4/asset/7d856d37-1b1d-4481-9723-c6f28077488d/main.assets/gr2_lrg.jpg)
Here's a research paper about that (abstract - the full paper is still in copyright and hidden behind a pay wall ): ncbi.nlm.nih.gov/pubmed/125
